Eczema: Types, Causes, Triggers and Treatment
Updated
Eczema is a group of inflammatory skin conditions that make the skin itchy, dry and inflamed, and its most common form is atopic dermatitis, which usually starts in early childhood and comes and goes in flares. Other common types are contact dermatitis, caused by something that touches the skin, dyshidrotic eczema (pompholyx), with small itchy blisters on the hands and feet, and nummular (discoid) eczema, with coin-shaped patches. Eczema is not contagious. It grows out of a weak skin barrier and an overactive immune response, and flares are set off by triggers such as soaps, heat, sweat, stress and allergens. This guide covers the main types, why eczema happens, common triggers, how it is diagnosed, the treatment classes from emollients to biologics, the signs of infection and when to see a doctor, following NICE, the American Academy of Dermatology (AAD) and the NHS.
For clinicians and students, the hard part of eczema is usually the next step rather than the diagnosis: which topical corticosteroid potency suits the face or the flexures, when a topical calcineurin inhibitor should take over, and which systemic agents current guidelines actually endorse. AskMed is a medical question app for doctors, nurses, pharmacists, medical students and researchers that searches clinical guidelines and studies before it answers, then links every claim to its source. Ask it how the NICE stepped approach matches topical corticosteroid potency to eczema severity and body site, and the answer quotes the recommendation it comes from.
Ask AskMed how eczema guidelines step treatment up by severity:
- Most common typeAtopic dermatitis, with a lifetime prevalence of up to 20%
- Other typesContact, dyshidrotic (pompholyx), nummular (discoid), hand, stasis and neurodermatitis
- DiagnosisHistory and skin examination; patch testing when contact allergy is suspected
- TreatmentEmollients for everyone, topical anti-inflammatories, then phototherapy, systemic or biologic therapy
- UrgentPainful, rapidly worsening eczema with clustered blisters or punched-out erosions (eczema herpeticum)
What is eczema?
Eczema is the everyday name for dermatitis, a set of inflammatory skin conditions that share itch, dryness and redness and, in active phases, oozing or tiny blisters, and atopic dermatitis is by far the most studied form. A 2018 review in Nature Reviews Disease Primers by Weidinger and colleagues calls atopic dermatitis the most common chronic inflammatory skin disease, with a lifetime prevalence of up to 20%, and a 2020 Lancet seminar by Langan, Irvine and Weidinger describes it as the leading cause of the global burden from skin disease. Atopic eczema affects people of all ages and ethnicities. The NHS says symptoms usually start in babies and young children and tend to improve with age, while the AAD notes that most children who develop atopic dermatitis do so by 5 years of age, that it can also begin at puberty and that onset in adulthood is less common. Eczema is not contagious, and although there is no cure, treatment controls it in most people.
Atopic eczema runs a relapsing course: flares, when the skin becomes drier, itchier, redder and more swollen, alternate with calmer periods. NICE guideline CG57 asks clinicians to explain that the condition often improves with time, but that not every child grows out of it and it can get worse in the teenage or adult years. It also sits within a wider atopic picture. The Lancet seminar links atopic dermatitis with a higher risk of food allergy, asthma, allergic rhinitis and mental health disorders, and the AAD describes the "atopic march", in which allergic diseases appear one after another, usually after the eczema. Not everyone follows that path, and some people develop asthma or hay fever first. The NHS adds that living with eczema can be hard and may affect mental health, and NICE points out that severity on the skin and the impact on sleep, school, work and mood are not always in step.
What are the main types of eczema?
The main types of eczema are atopic dermatitis, contact dermatitis, dyshidrotic eczema and nummular eczema, and the American Academy of Dermatology lists three more: hand eczema, neurodermatitis and stasis dermatitis. Atopic dermatitis is the chronic, relapsing form linked to asthma and hay fever, and the NHS says it most often affects the elbows, knees and hands, and the face in babies and toddlers. Contact dermatitis is caused by something that touches the skin. Dyshidrotic eczema, also called pompholyx, produces tiny, intensely itchy blisters on the fingers, palms and soles. Nummular eczema, called discoid eczema in the UK, forms round or oval patches that can be mistaken for ringworm. The types overlap: the AAD says nummular eczema is more common in people who already have atopic, stasis or contact dermatitis, and NICE notes that allergic contact dermatitis can complicate atopic eczema that was previously under control. Telling the types apart matters because the trigger, the tests and the emphasis of treatment differ.
- Atopic dermatitis: itchy, dry, scaly or thickened skin in the skin creases, elbows, knees and hands; face and extensor surfaces in infants. Linked to asthma and hay fever.
- Contact dermatitis: itchy rash, sometimes blistered, where an irritant or allergen touched the skin, most often the hands and face, hours or days after exposure.
- Dyshidrotic eczema (pompholyx): crops of tiny, very itchy fluid-filled blisters on the fingers, palms, toes and soles, often with burning or prickling first.
- Nummular (discoid) eczema: coin-shaped patches from a few millimetres to several centimetres, often on the hands, forearms or lower legs, rarely the face or scalp.
Atopic dermatitis
The NHS describes itchy skin that is dry, cracked, crusty, scaly or thickened, sometimes blistering or bleeding. The colour depends on skin tone: redness, or white, purple or grey patches, or skin that is lighter or darker than the skin around it. Flexural involvement, at the bends of the elbows and behind the knees, is the classic pattern, but NICE warns that in Asian, Black Caribbean and Black African children atopic eczema can affect the extensor surfaces instead, and discoid or follicular patterns may be more common.
Contact dermatitis
The NHS splits contact dermatitis into two kinds. Irritant contact dermatitis, the more common, happens when a substance such as soap, detergent, a solvent or frequent contact with water directly damages the outer layer of the skin. Allergic contact dermatitis is an immune reaction to an allergen, for example ingredients in cosmetics, metals such as nickel, or raw fruit and vegetables. The AAD notes that more than 15,000 substances can cause an allergic skin reaction, with fragrance and nickel among the commonest, and that the rash tends to appear hours or days after contact.
Dyshidrotic eczema (pompholyx)
Pompholyx comes and goes in episodes: the NHS says each one usually lasts 2 to 3 weeks, and the AAD that blisters may last 3 to 4 weeks before clearing. Once the blisters settle, the skin can be dry, cracked and sore. Suggested triggers include soaps and detergents, allergy or sensitivity to nickel or cobalt, frequently wet hands, stress, heat and sweat, and for some people the AAD describes flares every spring or summer.
Nummular (discoid) eczema
Discoid eczema starts as small spots or bumps that merge into round or oval patches, which are swollen, blistered and oozing early on and dry, crusty and flaky later. The NHS notes that the centre can clear and leave a ring, which is why it is sometimes mistaken for ringworm, and the AAD adds psoriasis as another lookalike. Unlike atopic eczema, discoid eczema does not seem to run in families. Very dry skin, minor skin injuries, stress and some medicines can set it off, and it tends to return in the same place.
Why does eczema happen? The skin barrier and the immune system
Eczema happens when a leaky skin barrier and an overactive immune response feed each other against a background of inherited risk, according to the 2018 Nature Reviews Disease Primers review of atopic dermatitis. The barrier is the stratum corneum, the outer layer of the skin, which the AAD compares to a brick wall: in atopic dermatitis the wall has gaps that let moisture escape, causing dryness, and let irritants, allergens and microbes in, causing inflammation and infection. One known cause of a weak barrier is a deficiency of filaggrin, a structural protein of the epidermis. The immune response in atopic dermatitis is skewed towards T helper 2 (type 2) pathways, and that inflammation in turn disrupts the barrier further. The review also names overgrowth of Staphylococcus aureus on the skin, IgE-mediated sensitisation and neuroinflammation that drives itch. The 2020 Lancet seminar adds that, although type 2 mechanisms dominate, several immune pathways are involved, which helps explain why targeted treatments work in different ways.
Genes set the background. The AAD reports that about 70% of people with atopic dermatitis have one or more blood relatives with atopic dermatitis or an allergic disease such as asthma or hay fever, and the NHS says eczema is more likely when one or both parents have it or when a close relative has asthma or hay fever. Environment matters too: the AAD cites studies showing that, in the United States, Black children are twice as likely as white children to develop atopic dermatitis, that people living in cities are more likely to develop it than people in rural areas, possibly because of air pollution, and that a dry climate or living far from the equator may increase the risk. Contact dermatitis works differently: in the irritant form the substance damages the skin directly, while in the allergic form the immune system has become sensitised to a specific allergen, which is why the same rash can return each time the skin meets it.
What triggers eczema flares?
Eczema flares are commonly triggered by irritants, allergens, heat and sweat, infection and stress, although NICE and the AAD both stress that triggers vary between people and some people never find a specific one. The NHS lists soap, washing detergent, pets, some fabrics, pollen, house-dust mites and certain foods, plus heat or temperature changes, skin infections such as a staph infection, stress and hormonal changes such as pregnancy. The AAD adds skin care products, cold or hot weather, wool clothing, fragrance and perfumes, and harsh detergents. NICE guideline CG57 on atopic eczema in children asks clinicians to look for five groups of trigger factors: irritants such as soaps, shampoos, bubble baths and shower gels; skin infections; contact allergens; food allergens; and inhalant allergens. The same guideline says the role of stress, humidity and extremes of temperature in causing flares is unclear, but advises avoiding them when possible. A flare shows as increased dryness, itching, redness, swelling and general irritability.
Food and other allergies
Allergy is the trigger question families ask most, and the guidance is more cautious than many expect. The AAD says that in most cases atopic dermatitis is not caused or triggered by a specific allergy, and the NHS advises against changing the diet unless a doctor recommends it. NICE suggests considering food allergy in children who have had immediate symptoms after eating a particular food, and in babies and young children with moderate or severe eczema that has not been controlled by optimal management, particularly with colic, vomiting, altered bowel habit or failure to thrive. It reassures that most children with mild atopic eczema do not need allergy tests and advises against high street or internet allergy tests, which have no proven value. Inhalant allergy is worth considering with seasonal flares, with asthma or allergic rhinitis, or with facial eczema, particularly around the eyes, from age 3. Allergic contact dermatitis should be suspected when previously controlled eczema flares or the skin reacts to topical treatments.
How is eczema diagnosed?
Eczema is diagnosed clinically, from the history and an examination of the skin, and most people need no tests: the AAD says a skin exam with information about health and symptoms may be all a dermatologist needs, and that a skin biopsy is only sometimes required. NICE guideline CG57 gives a structured rule for children: diagnose atopic eczema when a child has an itchy skin condition plus three or more of visible flexural dermatitis (or, at 18 months or younger, dermatitis on the cheeks or extensor areas), a history of flexural dermatitis, dry skin in the last 12 months, asthma or allergic rhinitis (or, under age 4, atopic disease in a first-degree relative) and onset before age 2, a criterion not used under age 4. The history covers onset, pattern and severity, the response to past treatment, possible triggers, diet, growth and development, and personal and family history of atopy.
Patch testing for contact allergy
When contact allergy is a possibility, a dermatologist can use patch testing to identify the specific allergen. NICE recommends referral when allergic contact dermatitis is suspected, for example in persistent eczema or eczema on the face, eyelids or hands, and the NHS says a GP may refer to a dermatologist for further tests when the trigger cannot be found or symptoms do not respond, or when a patch test is needed for discoid eczema. The AAD stresses that avoiding the cause is the only way to clear contact dermatitis, so finding it is worth the effort.
Grading severity
NICE grades atopic eczema as clear, mild (areas of dry skin, infrequent itching), moderate (frequent itching and redness, with or without excoriation and localised skin thickening) or severe (widespread dry skin, incessant itching and redness, with or without extensive thickening, bleeding, oozing, cracking and pigment change). Quality of life is graded separately, from no impact to nightly loss of sleep, because the look of the skin and the impact on daily life do not always match. NICE suggests the Patient-Oriented Eczema Measure (POEM) for severity and the CDLQI, IDQoL or Dermatitis Family Impact questionnaire for quality of life, and asks clinicians to treat areas of differing severity separately.
Applying these criteria at the bedside raises practical questions, especially in infants and on darker skin, where the flexural pattern may be absent and erythema harder to see. Ask AskMed how the NICE diagnostic criteria for atopic eczema change for children aged 18 months or under, or when patch testing is indicated for hand or eyelid dermatitis, and it answers from the guideline text with a source link after each statement, so a trainee can check the exact wording before presenting the case.
Ask AskMed about eczema diagnostic criteria and patch testing:
How is eczema treated?
Eczema treatment is built in steps on a base of emollients, and the step depends on severity: NICE guideline CG57 says emollients are the basis of management and should always be used, even when the skin is clear, with other treatments added or withdrawn as the eczema worsens or settles. For mild atopic eczema NICE pairs emollients with mild-potency topical corticosteroids; for moderate eczema it adds moderate-potency topical corticosteroids, topical calcineurin inhibitors and bandages; and for severe eczema, potent topical corticosteroids, topical calcineurin inhibitors, bandages, phototherapy and systemic therapy. The American Academy of Dermatology's 2023 guideline on topical therapy in adults makes strong recommendations for moisturizers, topical corticosteroids, topical calcineurin inhibitors and topical PDE-4 and JAK inhibitors, a conditional recommendation for bathing and wet wrap therapy, and conditional recommendations against topical antimicrobials, antiseptics and antihistamines. The product, potency and schedule for each body site are set by the prescriber; this guide names treatment classes only.
- Every severity, even when clear: emollients, used more often and in larger amounts than any other treatment.
- Mild: emollients plus a mild-potency topical corticosteroid.
- Moderate: emollients, a moderate-potency topical corticosteroid, topical calcineurin inhibitors and bandages.
- Severe: emollients, a potent topical corticosteroid, topical calcineurin inhibitors, bandages, then phototherapy or systemic therapy under specialist care.
Emollients and skin care
NICE recommends unperfumed emollients every day for moisturising, applied to the whole body in larger amounts and more often than other treatments, smoothed on rather than rubbed in, and leave-on emollients or emollient soap substitutes instead of soaps and detergent-based washes. Since 2023 NICE advises against prescribing emollient bath additives, after the BATHE trial found no added benefit. The NHS advises against aqueous cream, and NICE repeats the MHRA warning that emollient residue on clothing and bedding is a fire hazard.
Topical corticosteroids and calcineurin inhibitors
NICE says the benefits of topical corticosteroids outweigh possible harms when they are applied correctly, with potency matched to severity and body site: mild potency on the face and neck except for short courses in severe flares, and no very potent preparations in children without specialist advice. If eczema does not settle, NICE asks clinicians to exclude bacterial or viral infection before stepping up. The topical calcineurin inhibitors tacrolimus ointment and pimecrolimus cream are not first-line treatments; NICE positions tacrolimus as a second-line option for moderate to severe eczema not controlled by topical corticosteroids, especially where further steroid use risks important adverse effects, particularly irreversible skin atrophy, and suggests considering a calcineurin inhibitor for facial eczema that needs frequent mild steroid use. Newer non-steroid creams include the PDE-4 inhibitors crisaborole and roflumilast, the JAK inhibitor ruxolitinib and tapinarof; the AAD's 2025 focused update strongly recommends tapinarof and roflumilast cream.
Phototherapy, systemic and biologic treatment
When topical treatment is not enough, the AAD's 2024 guideline on phototherapy and systemic therapy for adults makes strong recommendations for the biologics dupilumab and tralokinumab and the oral JAK inhibitors abrocitinib, baricitinib and upadacitinib; conditional recommendations for phototherapy, azathioprine, cyclosporine, methotrexate and mycophenolate; and a conditional recommendation against systemic corticosteroids. The 2025 focused update adds strong recommendations for the biologics lebrikizumab and nemolizumab alongside topical therapy. The AAD notes that the first of the newer FDA-approved systemic treatments arrived in 2017, that dupilumab is approved from 6 months of age, and that its most common side effects in trials include injection-site reactions, inflamed eyes or eyelids and cold sores. For children, NICE reserves phototherapy and systemic treatment for severe eczema when other options have failed and quality of life is badly affected, under specialist supervision.
Treating the other types
For contact dermatitis the key step is avoiding the irritant or allergen, with emollients and topical corticosteroids for symptoms; the NHS says oral corticosteroids are needed only rarely, for severe episodes over large areas. Pompholyx is treated with emollients and topical steroids, potassium permanganate soaks for weeping blisters and antibiotics if blisters become infected, while specialists may use steroid tablets, UV light therapy or alitretinoin, and the AAD reports dupilumab helping a small number of hard-to-treat patients. Discoid eczema is managed with emollients, topical corticosteroids, antihistamines for itch and antibiotics for infection.
The systemic tier is where eczema guidance changes fastest: between 2023 and 2025 the AAD added strong recommendations for several biologics and JAK inhibitors, and the choice between them turns on age, comorbidities, monitoring and pregnancy plans. Ask AskMed which systemic agents carry strong rather than conditional AAD recommendations for adult atopic dermatitis, or what baseline screening is advised before starting an oral JAK inhibitor, and the answer links each point to the guideline, drug label or trial it comes from.
Compare systemic and biologic options for atopic dermatitis in AskMed:
What are the signs of infected eczema?
The signs of infected eczema are skin that suddenly weeps, crusts or develops pus-filled spots, becomes painful, swollen or hot, worsens or spreads quickly, or stops responding to usual treatment, sometimes with fever or feeling generally unwell. NICE guideline CG57 lists the signs of bacterial infection with Staphylococcus or Streptococcus as weeping, pustules, crusts, eczema failing to respond to therapy, rapidly worsening eczema, fever and malaise. The NHS advises an urgent GP appointment or a call to NHS 111 when eczema is blistered, crusty, leaking fluid or has pus-filled spots, is painful, swollen or warm, suddenly gets worse or spreads, or comes with a high temperature or feeling unwell. People with atopic dermatitis are prone to infection because, as the AAD explains, gaps in the skin barrier let bacteria and viruses in. After an infection has been treated, NICE advises getting new supplies of topical eczema treatments, because the old ones can become contaminated and act as a source of reinfection.
Eczema herpeticum: an emergency
Eczema herpeticum is widespread herpes simplex infection on eczematous skin. NICE describes areas of rapidly worsening, painful eczema, clustered blisters that look like early cold sores, and punched-out erosions, usually 1 mm to 3 mm across and uniform in appearance, which can merge into larger crusted areas, possibly with fever, lethargy or distress. NICE advises starting systemic aciclovir immediately and referring for same-day specialist dermatology advice, and same-day ophthalmology review as well when the skin around the eyes is involved. Herpes simplex should also be considered when infected eczema fails to respond to antibiotics and an appropriate topical corticosteroid.
When should you see a doctor about eczema?
You should see a doctor about eczema when you first notice the symptoms, when treatment is not helping, and urgently if there are signs of infection or eczema herpeticum. The NHS suggests seeing a GP for symptoms of atopic eczema or when treatments are not working, says a pharmacist can advise on mild cases, and advises an urgent appointment or NHS 111 for eczema that is blistered, crusty, oozing, painful, hot or spreading, or that comes with a high temperature. NICE CG57 sets referral rules for children: same-day referral for suspected eczema herpeticum; urgent referral, within 2 weeks, when severe eczema has not responded to optimal topical therapy after 1 week or when treatment of bacterially infected eczema has failed; and routine referral when the diagnosis is uncertain, control is poor, facial eczema is not responding, contact allergy is suspected, the eczema causes significant social or psychological problems, or there are severe recurrent infections such as deep abscesses or pneumonia.
For adults, the same signals apply in practice: eczema that keeps flaring despite regular emollients and correctly used topical treatment, eczema on the hands or face that may be work-related or allergic, and itch that disturbs sleep or mood are all reasons to ask about referral to a dermatologist, who can offer patch testing, phototherapy or systemic treatment. The NHS notes that a GP can refer to a mental health specialist when eczema affects mental health, and NICE recommends psychological support when the skin improves but quality of life does not. Anyone with eczema who becomes suddenly unwell with painful, rapidly spreading blisters or sores should get same-day medical care.
Frequently asked questions
Is eczema contagious?
No. The NHS says atopic eczema is not contagious, and the AAD says the same of contact and dyshidrotic eczema. Infected eczema is different: the bacteria or herpes simplex virus causing the infection can spread, which is why weeping, crusted or blistered eczema needs prompt treatment.
Do children grow out of eczema?
Many do. The AAD says atopic dermatitis goes away by the teenage years for many children, although it can return later or continue for life. NICE asks clinicians to explain that eczema often improves with time but that not every child grows out of it, and it may get worse in teenage or adult life.
Is eczema caused by a food allergy?
Usually not. The AAD says atopic dermatitis is in most cases not caused or triggered by a specific allergy. NICE suggests considering food allergy after immediate reactions to a food, or in babies with moderate to severe eczema not controlled by optimal treatment, and says most children with mild eczema do not need allergy tests.
Are steroid creams safe for eczema?
Used correctly, yes. NICE says the benefits of topical corticosteroids outweigh possible harms when they are applied correctly, with potency matched to severity and body site, mild potency on the face and neck, and no very potent preparations in children without specialist advice. The prescriber sets the product and how long to use it.
What is the difference between eczema and atopic dermatitis?
Eczema is the umbrella term for a group of itchy, inflammatory skin conditions, while atopic dermatitis is its most common type, the one linked to asthma and hay fever. People often use the two words for the same condition, and the AAD writes "atopic dermatitis, also called eczema", but contact, dyshidrotic and nummular eczema are separate types.
Sources
- National Institute for Health and Care Excellence. Atopic eczema in under 12s: diagnosis and management (CG57). NICE clinical guideline, 2007, last updated 22 September 2025.
- Sidbury R, Alikhan A, Bercovitch L, et al. Guidelines of care for the management of atopic dermatitis in adults with topical therapies. J Am Acad Dermatol. 2023;89(1):e1-e20.
- Davis DMR, Drucker AM, Alikhan A, et al. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies. J Am Acad Dermatol. 2024;90(2):e43-e56.
- Davis DMR, Frazer-Green L, Alikhan A, et al. Focused update: Guidelines of care for the management of atopic dermatitis in adults. J Am Acad Dermatol. 2025;93(3):745.e1-745.e7.
- Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat Rev Dis Primers. 2018;4(1):1.
- Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396(10247):345-360.
- NHS. Atopic eczema. Last reviewed 6 September 2024.
- NHS. Contact dermatitis (reviewed 3 May 2023), Pompholyx (reviewed 30 July 2026) and Discoid eczema (reviewed 23 March 2023).
- American Academy of Dermatology. Eczema types, atopic dermatitis causes, atopic dermatitis diagnosis and treatment, contact dermatitis, dyshidrotic eczema and nummular eczema. Accessed 16 November 2026.
